Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 90658

7 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 22, 2022
Product types
Device
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Baxter Healthcare Corporation

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

7 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Yellow: a) 25 pack, REF H93866025, b) 100 pack, REF H93866100, c) 25 pack, REF H938690025

Z-1575-2022
Recall number
Z-1575-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
602340 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

a) REF H93866025, UDI 00085412478845, ALL LOTS; b) REF H93866100, UDI 00085412478852, ALL LOTS; c) REF H938690025, UDI 00085412479941, ALL LOTS

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.

device · product 2 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Orange: a) 25 pack, REF H93867025, b) 100 pack, REF H93867100

Z-1576-2022
Recall number
Z-1576-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
63190 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

a) REF H93867025, UDI 00085412478869, ALL LOTS; b) REF H93867100, UDI 00085412478890, ALL LOTS

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.

device · product 3 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, White REF H938671100

Z-1577-2022
Recall number
Z-1577-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
10140 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

REF H938671100, UDI 00085412479750

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.

device · product 4 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Dark Blue: a) 25 pack REF H938693025, b) 100 pack REF H938673100

Z-1578-2022
Recall number
Z-1578-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
24,320 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

a) 25 pack REF H938693025, UDI 00085412479965, ALL LOTS; b) 100 pack REF H938673100, UDI 00085412479798, ALL LOTS

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.

device · product 5 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Green: a) 25 pack, REF H93869025, b) 100 pack, REF H938674100, c) 100 pack, REF H93869100

Z-1579-2022
Recall number
Z-1579-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
168390 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

a) 25 pack, REF H93869025, UDI 00085412479965, ALL LOTS; b) 100 pack, REF H938674100, UDI 00085412479811, ALL LOTS; c) 100 pack, REF H93869100, UDI 00085412478944, ALL LOTS

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.

device · product 6 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Pink, 100 pack, REF H938676100

Z-1580-2022
Recall number
Z-1580-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
9700 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

REF H938676100, UDI 00085412479859, ALL LOTS

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.

device · product 7 of 7

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Purple, 100 pack, REF H938677100

Z-1581-2022
Recall number
Z-1581-2022
Initiated
July 22, 2022
Classification
Class II
Status
Ongoing
Quantity
8500 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

Code information

REF H938677100 , UDI 00085412479873, ALL LOTS

Distribution pattern

Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.